|1|Prostate tumor overexpressed 1 is a novel prognostic marker for hepatocellular carcinoma progression and overall patient survival. (25634174)
Chen S.P.... Jiang N.
|2|Expression of hepatocyte growth factor in prostate cancer may indicate a biochemical recurrence after radical prostatectomy. (25550581)
Nishida S.... Masumori N.
|3|I^-Arrestin2 Contributes to Cell Viability and Proliferation via the Down-Regulation of FOXO1 in Castration-Resistant Prostate Cancer. (25752515)
Duan X.... Zeng G.
|4|Targeting the MLL complex in castration-resistant prostate cancer. (25822367)
Malik R.... Chinnaiyan A.M.
|5|Identification of a genetic interaction between the tumor suppressor EAF2 and the retinoblastoma protein (Rb) signaling pathway in C. elegans and prostate cancer cells. (24727455)
Cai L.... Wang Z.
|6|Measurement of serum PSA as a predictor of symptoms scored on the IPSS for patients with benign prostatic hyperplasia. (24548953)
Lim C.F.... Buchan N.C.
|7|Lumican expression, localization and antitumor activity in prostate cancer. (23399832)
Coulson-Thomas V.J.... Nader H.B.
|8|Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines. (23676682)
Pickard M.R.... Williams G.T.
|9|Pre-prostatic tissue removed in robotic assisted lymph node dissection for prostate cancer contains lymph nodes. (24311906)
Blarer J.... Horstmann M.
|10|No evidence of FGFR3 mutations in prostate cancer. (20957671)
Zuiverloon T.C.... Zwarthoff E.C.
|11|Clusterin facilitates COMMD1 and I-kappaB degradation to enhance NF- kappaB activity in prostate cancer cells. (20068069)
Zoubeidi A.... Gleave M.E.
|12|CYP17 polymorphisms and prostate cancer outcomes. (20503394)
Wright J.L.... Stanford J.L.
|13|Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling. (18824345)
Kwon G.T.... Park J.H.
|14|Y chromosome haplotypes and prostate cancer in Sweden. (18927315)
LindstrAPm S.... Wiklund F.
|15|A feedback loop between the androgen receptor and a NEDD4-binding protein, PMEPA1, in prostate cancer cells. (18703514)
Li H.... Srivastava S.
|16|Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk: a replication study in an ethnically homogeneous population. (18537123)
FitzGerald L.M.... Dickinson J.L.
|17|A common 8q24 variant in prostate and breast cancer from a large nested case-control study. (17409400)
Schumacher F.R.... Hunter D.J.
|18|P2Y purinergic receptor activated PI-3K/Akt signaling pathway in regulation of growth and invasion of prostatic cancer]. (18194602)
Wang Y.X.... Fang W.G.
|19|Phase II study evaluating oral triamcinolone in patients with androgen-independent prostate cancer. (16698360)
Srinivas S.... Feldman D.
|20|Sprouty4, a suppressor of tumor cell motility, is down regulated by DNA methylation in human prostate cancer. (16388505)
Wang J.... Kwabi-Addo B.
|21|The hidden condition: status, challenges, and opportunities in the management of enlarged prostate for managed care. (16551205)
Naslund M.J.... Eaddy M.T.
|22|Heat induced release of Hsp70 from prostate carcinoma cells involves both active secretion and passive release from necrotic cells. (17079215)
Mambula S.S.... Calderwood S.K.
|23|Characterization of frequently deleted 6q locus in prostate cancer. (17132090)
Sun M.... Srivastava S.
|24|Targeting stathmin in prostate cancer. (16373697)
Mistry S.J.... Atweh G.F.
|25|A novel knock-in prostate cancer model demonstrates biology similar to that of human prostate cancer and suitable for preclinical studies. (15727931)
Gabril M.Y.... Xuan J.W.
|26|An antagonist of retinoic acid receptors more effectively inhibits growth of human prostate cancer cells than normal prostate epithelium. (15266311)
Keedwell R.G.... Brown G.
|27|Epidermal growth factor, neurotrophins and the metastatic cascade in prostate cancer. (15280008)
Montano X.... Djamgoz M.B.
|28|Microarray analysis of prostate cancer progression to reduced androgen dependence: studies in unique models contrasts early and late molecular events. (15390081)
Sirotnak F.M.... Scher H.I.
|29|A comparative study of prostate specific antigen (PSA), C-terminal propeptide of blood type I procollagen (PICP) and urine type I collagen-crosslinked N telopeptide (NTx) levels using bone scintigraphy in prostate cancer patients. (12932112)
Fukumitsu N.... Nakada J.
|30|Metastatic prostate cancer with normal level of serum prostate-specific antigen. (15072491)
Nishio R.... Fuse H.
|31|Evidence for activation of the renin-angiotensin system in the human prostate: increased angiotensin II and reduced AT(1) receptor expression in benign prostatic hyperplasia. (11793373)
Dinh D.T.... Fabiani M.E.
|32|A phase II Hoosier Oncology Group study of vinorelbine and estramustine phosphate in hormone-refractory prostate cancer. (11996476)
Sweeney C.J.... Einhorn L.H.
|33|Differential activation of the IGF binding protein-3 promoter by butyrate in prostate cancer cells. (11956160)
Tsubaki J.... Rosenfeld R.G.
|34|Inhibition of nuclear factor kappaB induces apoptosis following treatment with tumor necrosis factor alpha and an antioxidant in human prostate cancer cells. (12269771)
Gunawardena K.... Meikle A.W.
|35|Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity. (11929948)
Jing C.... Ke Y.
|36|Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells. (11228105)
Chung L.Y.... Kwok T.T.
|37|Contrasting effects of aspirin on prostate cancer cells: suppression of proliferation and induction of drug resistance . (10639187)
Rotem R.... Flescher E.
|38|Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review. (11141722)
D'Aprile M.... Tonini G.
|39|BRCA1 and BRCA2 have a limited role in familial prostate cancer. (10728701)
Sinclair C.S.... Couch F.J.
|40|Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer. (10475365)
Duque J.L.... Freeman M.R.
|41|Clinical pharmacokinetics of the antiandrogens and their efficacy in prostate cancer. (9592622)
Mahler C.... Denis L.
|42|Immunocytochemical localization of an immunoconjugate (antibody IgG against prostatic acid phosphatase conjugated to 5-fluoro-2'-deoxyuridine) in human prostate tumors. (9673345)
Sinha A.A.... Gleason D.F.
|43|Selective expression of inducible nitric oxide synthase in human prostate carcinoma. (9587122)
Klotz T.... Addicks K.
|44|NGF-beta, NE-cells and prostatic cancer cell lines. A study of neuroendocrine expression in the human prostatic cancer cell lines DU-145, PC-3, LNCaP, and TSU-pr1 following stimulation of the nerve growth factor-beta. (9561567)
Angelsen A.... Waldum H.L.
|45|Steroid-involved transcriptional regulation of human genes encoding prostatic acid phosphatase, prostate-specific antigen, and prostate-specific glandular kallikrein. (9275063)
Shan J.D.... Vihko P.
|46|Free and total serum PSA values in patients with prostatic intraepithelial neoplasia (PIN), prostate cancer and BPH. Is F/T PSA a potential probe for dormant and manifest cancer? (9179191)
Tarle M.... KraljiA8 I.
|47|Sorting of heparan sulfate proteoglycan into matrix compartments of prostate adenocarcinoma cells. (7830405)
Kosir M.A.... Quinn C.C.
|49|Variability of values of prostate-specific antigen determined with 6 methods]. (7514278)
Bangma C.H.... SchrAPder F.H.
|50|Remarks on a New Mode of Affording Permanent Relief to Intractable Chronic Cystitis, and to Confirmed Prostatic Retention of Urine. (20750395)